Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Nephrology

Daily Care: Treatments and Management Strategies

At a Glance

HNF1B-related disease needs individualized, multi-system care. Treatment may include kidney-protective medicines, magnesium or potassium replacement, insulin for MODY5 diabetes, pancreatic enzymes, and gout therapy, with regular lab monitoring and sick-day safety.

Managing HNF1B-related disease or 17q12 deletion syndrome requires a coordinated approach that addresses each system affected by the gene change. Because the condition is so variable, there is no “one-size-fits-all” treatment; instead, your care team will create a plan based on your specific lab results and symptoms [1].

Protecting Your Kidneys

The primary goal of kidney management is to slow the progression of Chronic Kidney Disease (CKD) and maintain a healthy balance of minerals in the blood.

  • Blood Pressure and Proteinuria: If you have high blood pressure or protein in your urine (proteinuria), doctors often prescribe ACE inhibitors (like lisinopril) or ARBs (like losartan). These medications are “kidney-protective” because they reduce the pressure inside the kidney’s filtering units and have been shown to slow the decline of kidney function [2][3].
  • Monitoring: You will likely have regular blood tests to check your eGFR (filtering rate) and urine tests to check for protein. These medications are not automatically for every patient and require follow-up of creatinine and potassium.

Balancing Electrolytes (Magnesium and Potassium)

Because the kidneys “waste” certain minerals into the urine, many people need daily supplements. However, magnesium and potassium should be replaced only when laboratory results and clinical circumstances indicate a need, not automatically. Excess minerals can be harmful in CKD.

  • Magnesium: This is a cornerstone of management. Oral magnesium is used for long-term maintenance [4]. While many types exist, organic forms like magnesium glycinate, aspartate, or gluconate are sometimes preferred because they may be better absorbed and are less likely to cause diarrhea than inorganic forms like magnesium oxide [5][6]. Do not encourage self-selection of high-dose supplements without supervision.
  • Potassium: If your potassium levels are low (hypokalemia), you may need potassium supplements. Interestingly, it can be very difficult to raise potassium levels if your magnesium is also low, so both usually need to be corrected together [7][8].
  • Advanced Options: For those whose magnesium stays very low despite high-dose supplements, doctors may sometimes add “potassium-sparing” diuretics like amiloride, which help the kidneys hold onto magnesium [9]. These require strict supervision as they can cause high potassium, low blood pressure, or worsening kidney function.

Managing Diabetes (MODY5)

Diabetes in this condition (MODY5) is different from the more common Type 1 or Type 2 diabetes.

  • Treatment: Treatment is selected according to residual insulin secretion, glucose patterns, age, and kidney function. While some people may initially respond to oral medications called sulfonylureas, insulin is frequently needed for most people with MODY5 [1][10]. This is because the pancreas often has a physical shortage of insulin-producing cells. These decisions belong to your endocrinology team.
  • Monitoring: Regular checks of your HbA1c (average blood sugar) are essential. Because diabetes can affect the small blood vessels over time, you should also have regular eye exams (to check for retinopathy) and foot exams (to check for neuropathy) [10][11].

Digestion and the Pancreas

If you have pancreatic exocrine insufficiency (the pancreas isn’t making enough digestive enzymes), you may experience weight loss or oily stools [12].

  • Diagnosis: This is confirmed with a fecal elastase-1 stool test. A result below 200 μg/g suggests possible insufficiency, though watery stool can produce a falsely low result [12].
  • PERT: The treatment is Pancreatic Enzyme Replacement Therapy (PERT). These are capsules taken with every meal and snack that provide the enzymes your body is missing. Dosing and response should be supervised by your GI team. This often leads to rapid improvement in symptoms and healthy weight gain [12].

Handling Gout and Uric Acid

High uric acid (hyperuricemia) is common. Asymptomatic hyperuricemia is often not treated routinely, but decisions consider history of flares, tophi, or uric-acid stones [13].

  • Urate-Lowering Therapy: If you have frequent gout flares, doctors use medications like allopurinol to lower uric acid levels. The goal is typically to keep your blood urate level below 6 mg/dL [13][14].
  • Flares: Acute flares are managed with anti-inflammatory medications like colchicine or low-dose steroids, though these must be used carefully in people with kidney disease and require CKD dosing [13][15].

Important Safety Information

Sick-Day and Medication Safety
If you have CKD, you must protect your kidneys day-to-day:

  • NSAIDs: Avoid non-steroidal anti-inflammatory drugs (like ibuprofen or naproxen) and over-the-counter herbal products unless specifically approved by your nephrologist, as they can reduce kidney function.
  • Sick Days: Ask your team for a “sick day plan.” If you have severe vomiting, diarrhea, or dehydration, you may need to temporarily stop certain medications (like ACE inhibitors, ARBs, or diuretics) to prevent acute kidney injury.
  • Supplements: Do not make drastic changes to fluid, salt, potassium, magnesium, or protein intake without individualized advice.

When to Seek EMERGENCY Care
While most aspects of HNF1B-related disease are managed routinely, some situations require immediate emergency triage. Call 911 or go to the emergency room for:

  • Fainting, seizures, or severe confusion.
  • Chest pain, sustained palpitations, or an irregular heartbeat (which can be a sign of severe electrolyte lows) [4][16].
  • Severe muscle weakness or inability to stand.
  • Inability to treat a low blood glucose (hypoglycemia).
  • Vomiting accompanied by abdominal pain or rapid breathing (possible diabetic ketoacidosis).
  • Markedly reduced or stopped urine output.

Common questions in this guide

How is HNF1B-related disease managed day to day?
Management is individualized because HNF1B-related disease can affect the kidneys, electrolytes, pancreas, blood sugar, and uric acid. Care may include regular blood and urine tests, kidney-protective medicines, mineral replacement, diabetes treatment, pancreatic enzymes, and gout treatment when needed.
Can ACE inhibitors or ARBs protect my kidneys in HNF1B disease?
ACE inhibitors or ARBs may be prescribed when high blood pressure or protein in the urine is present because they can reduce pressure in the kidney’s filtering units and slow loss of function. They are not right for everyone and require follow-up of creatinine, potassium, blood pressure, and kidney function.
How are low magnesium and potassium treated in HNF1B-related disease?
Magnesium and potassium supplements should be based on blood-test results and your clinical situation because excess amounts can be dangerous when kidney function is reduced. Low magnesium can make low potassium difficult to correct, and medicines such as amiloride require close monitoring because they can raise potassium or worsen kidney function.
Will MODY5 diabetes require insulin?
Treatment depends on how much insulin your pancreas still makes, your glucose pattern, age, and kidney function. Some people may respond initially to sulfonylureas, but insulin is frequently needed in MODY5 because the pancreas may have fewer insulin-producing cells.
How do I know if I need pancreatic enzymes?
Weight loss or oily stools can suggest pancreatic exocrine insufficiency, which can be evaluated with a fecal elastase-1 stool test. Pancreatic enzyme replacement therapy is taken with meals and snacks when indicated, with dosing supervised by a gastrointestinal team.
When should high uric acid or gout be treated?
High uric acid without symptoms is not always treated; decisions consider gout attacks, tophi, or uric-acid kidney stones. Frequent flares may be treated with allopurinol, while an acute flare may require colchicine or a low-dose steroid with dosing adjusted for kidney function.
What should I do about medications during vomiting, diarrhea, or dehydration?
Ask your medical team for a sick-day plan before an illness occurs. Severe vomiting, diarrhea, or dehydration may require temporarily stopping medicines such as ACE inhibitors, ARBs, or diuretics, and NSAIDs such as ibuprofen or naproxen should not be used unless your kidney specialist approves them.

Get notified when new evidence is published on HNF1B-related autosomal dominant tubulointerstitial kidney disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update.

    Zagaroli L, Di Berardino A, Petragnano F, et al.

    Diabetes therapy : research, treatment and education of diabetes and related disorders 2026; (17(7)):959-983 doi:10.1007/s13300-026-01884-2.

    PMID: 42295651
  2. 2

    Blood pressure in children with renal cysts and diabetes syndrome.

    Seeman T, Weigel F, Blahova K, et al.

    European journal of pediatrics 2021; (180(12)):3599-3603 doi:10.1007/s00431-021-04165-1.

    PMID: 34176013
  3. 3

    Use of renin-angiotensin-aldosterone system blockade in controversial chronic kidney disease populations.

    García-Prieto AM, Verdalles Ú, Goicoechea M

    Medicina clinica 2021; (156(11)):561-567 doi:10.1016/j.medcli.2020.12.025.

    PMID: 33757646
  4. 4

    Acquired Disorders of Hypomagnesemia.

    Rosner MH, Ha N, Palmer BF, Perazella MA

    Mayo Clinic proceedings 2023; (98(4)):581-596 doi:10.1016/j.mayocp.2022.12.002.

    PMID: 36872194
  5. 5

    Hypomagnesemia from malabsorption and renal magnesium wasting treated with high-dose magnesium glycinate: A case report.

    Tran BAC, Miller T

    Journal of the American Pharmacists Association : JAPhA 2026; 103496 doi:10.1016/j.japh.2026.103496.

    PMID: 42567449
  6. 6

    The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman's and Bartter's Syndromes.

    Francini F, Gobbi L, Ravarotto V, et al.

    Nutrients 2021; (13(9)) doi:10.3390/nu13092960.

    PMID: 34578838
  7. 7

    Hypokalemia-Induced Rhabdomyolysis with Coexisting Hypomagnesemia: A Case Report.

    Migita K, Yamasaki K, Takenaka Y, et al.

    The Tohoku journal of experimental medicine 2025; (267(3)):317-322 doi:10.1620/tjem.2025.J051.

    PMID: 40335297
  8. 8

    [Expert consensus for the diagnosis and treatment of patients with Gitelman syndrome].

    Zhonghua nei ke za zhi 2017; (56(9)):712-716 doi:10.3760/cma.j.issn.0578-1426.2017.09.021.

    PMID: 28870047
  9. 9

    The Clinical Spectrum of Acquired Hypomagnesemia: From Etiology to Therapeutic Approaches.

    Floris M, Angioi A, Lepori N, et al.

    Biomedicines 2025; (13(8)) doi:10.3390/biomedicines13081862.

    PMID: 40868117
  10. 10

    Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects.

    Dubois-Laforgue D, Cornu E, Saint-Martin C, et al.

    Diabetes care 2017; (40(11)):1436-1443 doi:10.2337/dc16-2462.

    PMID: 28420700
  11. 11

    Maturity-onset diabetes of the young secondary to HNF1B variants (HNF1B-MODY): a series of 10 patients from a single diabetes center.

    Amaral S, Palha A, Bogalho P, Silva-Nunes J

    Diabetology & metabolic syndrome 2023; (15(1)):21 doi:10.1186/s13098-022-00964-0.

    PMID: 36793123
  12. 12

    Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic.

    Clissold RL, Fulford J, Hudson M, et al.

    Clinical kidney journal 2018; (11(4)):453-458 doi:10.1093/ckj/sfx150.

    PMID: 30094008
  13. 13

    2020 American College of Rheumatology Guideline for the Management of Gout.

    FitzGerald JD, Dalbeth N, Mikuls T, et al.

    Arthritis care & research 2020; (72(6)):744-760 doi:10.1002/acr.24180.

    PMID: 32391934
  14. 14

    Management of Gout and Hyperuricemia in CKD.

    Vargas-Santos AB, Neogi T

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2017; (70(3)):422-439 doi:10.1053/j.ajkd.2017.01.055.

    PMID: 28456346
  15. 15

    2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common Comorbidities.

    Li C, Sun M, Liu Z, et al.

    International journal of rheumatic diseases 2025; (28(8)):e70402 doi:10.1111/1756-185x.70402.

    PMID: 40851321
  16. 16

    Close Call From a Sweet Twist: A Case of Licorice-Induced Torsades De Pointes.

    Molina-Lopez V, Engel-Rodriguez A, Escabi-Mendoza J

    Cureus 2023; (15(1)):e34126 doi:10.7759/cureus.34126.

    PMID: 36843745

This page is for informational purposes only and does not constitute medical advice. Your nephrology, endocrinology, and gastroenterology teams should tailor medicines, supplements, and sick-day instructions to your laboratory results and kidney function.